Peer-reviewedCC BYFrontiers in pharmacology
Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
- 1Division of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital , ,
Related
- Novel Autoantibodies in Rheumatoid Arthritis: Translational Prospects from Seronegative Breakthrough to Precision Diagnosis and Treatment.
- Juvenile idiopathic arthritis and rheumatoid arthritis: a narrative review of age-dependent, subtype-specific immune mechanisms, biomarkers, and treatment strategies
- A Preliminary Exploratory Study Based on LC–MS/MS and LFQ for Candidate Protein Biomarkers in Peripheral Blood from Rheumatoid Arthritis
- Successful Treatment of Recalcitrant Pyoderma Gangrenosum with Baricitinib in Two Patients with Rheumatoid Arthritis.
- Integrative proteomic and machine learning strategies identify key biomarkers associated with response to JAK inhibitor in rheumatoid arthritis.
BibTeX
@article{liu2026predictive,
title = {{Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?}},
author = {Jianyang Liu and Per-Johan Jakobsson},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655683},
note = {CC BY},
}
RIS
TY - JOUR
TI - Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
AU - Jianyang Liu
AU - Per-Johan Jakobsson
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13655683
SN - 1663-9812
ER -